$39.95
00.00%
Last update: 4:15 PM
15 minutes delayed
Principal Healthcare Innovators ETF (NASDAQ: BTEC)
Ticker | Name | Share % | |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc Common Stock Usd 0.01 | 5.20% | |
MRNA | Moderna Inc Restricted Common Stock | 3.49% | |
SRPT | Sarepta Therapeutics Inc | 3.16% | |
NTRA | Natera Inc | 2.80% | |
ILMN | Illumina, Inc. | 2.46% | |
CTLT | Catalent Pharma Solution 144a | 2.19% | |
INSM | Insmed Inc | 2.15% | |
ROIV | Roivant Sciences Ltd | 1.89% | |
PCVX | Vaxcyte Inc | 1.79% | |
EXAS | Exact Sciences Corp | 1.66% |
The BTEC ETF is currently trading at $39.95, which represents a 0.00% change. Over the past 52 weeks, the ETF has traded as high as $41.10 and as low as $25.66.
The expense ratio of BTEC is NA%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for BTEC is 16.20M. This represents the total market value of the assets managed by the ETF.
BTEC follows a Mid Cap Growth investment style.
The top holdings of BTEC include: ALNY (5.20%), MRNA (3.49%), SRPT (3.16%), NTRA (2.80%), ILMN (2.46%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for BTEC is currently not available.